OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Nectin-4-directed antibody-drug conjugates (ADCs): Spotlight on preclinical and clinical evidence
Mohammad Javad Khosravanian, Yousef Mirzaei, Ali Hussein Mer, et al.
Life Sciences (2024) Vol. 352, pp. 122910-122910
Closed Access | Times Cited: 7
Mohammad Javad Khosravanian, Yousef Mirzaei, Ali Hussein Mer, et al.
Life Sciences (2024) Vol. 352, pp. 122910-122910
Closed Access | Times Cited: 7
Showing 7 citing articles:
Laryngeal Squamous Cell Carcinoma Is Characterized by a Stronger Expression of Nectin-4 Compared to Nectin-2
Matej Maršić, Nives Jonjić, Maja Gligora Marković, et al.
Current Issues in Molecular Biology (2025) Vol. 47, Iss. 5, pp. 296-296
Open Access
Matej Maršić, Nives Jonjić, Maja Gligora Marković, et al.
Current Issues in Molecular Biology (2025) Vol. 47, Iss. 5, pp. 296-296
Open Access
Mechanism of action and future perspectives of ADCs in combination with immune checkpoint inhibitors for solid tumors
Yahui Lv, Xiaoran Cui, Tao Li, et al.
Clinical and Experimental Medicine (2025) Vol. 25, Iss. 1
Open Access
Yahui Lv, Xiaoran Cui, Tao Li, et al.
Clinical and Experimental Medicine (2025) Vol. 25, Iss. 1
Open Access
Prevalence of treatment-related adverse events (TRAEs) with antibody-drug conjugates in metastatic breast cancer patients: a systematic review and meta-analysis
Silvia Belloni, Paola Tiberio, Rita De Sanctis, et al.
Critical Reviews in Oncology/Hematology (2024) Vol. 204, pp. 104527-104527
Closed Access | Times Cited: 1
Silvia Belloni, Paola Tiberio, Rita De Sanctis, et al.
Critical Reviews in Oncology/Hematology (2024) Vol. 204, pp. 104527-104527
Closed Access | Times Cited: 1
Advancements in Clinical Research and Emerging Therapies for Triple-Negative Breast Cancer Treatment
Lili Xu, Pengtao Xu, Jingsong Wang, et al.
European Journal of Pharmacology (2024), pp. 177202-177202
Closed Access | Times Cited: 1
Lili Xu, Pengtao Xu, Jingsong Wang, et al.
European Journal of Pharmacology (2024), pp. 177202-177202
Closed Access | Times Cited: 1
Future investigative directions for novel therapeutic targets in head and neck cancer
Jacqueline P. Nguyen, Liam C Woerner, Daniel E. Johnson, et al.
Expert Review of Anticancer Therapy (2024) Vol. 24, Iss. 11, pp. 1067-1084
Closed Access
Jacqueline P. Nguyen, Liam C Woerner, Daniel E. Johnson, et al.
Expert Review of Anticancer Therapy (2024) Vol. 24, Iss. 11, pp. 1067-1084
Closed Access
Real-world Evidence for Enfortumab Vedotin in Patients with Metastatic Urothelial Cancer: An Austrian Multicentre Study
Dora Niedersuess-Beke, Karl Mayrhofer, Johanna Krauter, et al.
Clinical Genitourinary Cancer (2024), pp. 102278-102278
Open Access
Dora Niedersuess-Beke, Karl Mayrhofer, Johanna Krauter, et al.
Clinical Genitourinary Cancer (2024), pp. 102278-102278
Open Access
Unlocking Natural Potential: Antibody‐Drug Conjugates With Naturally Derived Payloads for Cancer Therapy
Xue Jiang, Wan Najbah Nik Nabil, Yufei Ze, et al.
Phytotherapy Research (2024)
Closed Access
Xue Jiang, Wan Najbah Nik Nabil, Yufei Ze, et al.
Phytotherapy Research (2024)
Closed Access
Immunoconjugates as an Efficient Platform for Drug Delivery: A Resurgence of Natural Products in Targeted Antitumor Therapy
Rositsa Mihaylova, Denitsa Momekova, Viktoria Elincheva, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 12, pp. 1701-1701
Open Access
Rositsa Mihaylova, Denitsa Momekova, Viktoria Elincheva, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 12, pp. 1701-1701
Open Access
